Presbyopia Therapies
Coronado, US · Founded 2013 · Delaware corporation · 1 known investors
Founders & leadership
Presbyopia Therapies was founded in 2013 by GERALD HORN.
GH
GERALD HORNMANAGER
ML
MARK LESTERMANAGER
JM
JAMES McCOLLUMMANAGER
Investors · 1
Reported raises · per SEC filings
Form D private placements$136.2M disclosed across 4 rounds · 2016–2023
▶$83.5MraisedMar 2023 · 27 investors · BiotechnologyRule 506(b)
▶$83.5MraisedMar 2023 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Evert SchimmelpenninkExecutive Officer, Director
- James McCollumDirector
- Clare OzawaDirector
- Zach ScheinerDirector
- Stefan LarsonDirector
- Frederic GuerardDirector
- Chris DimitropoulosDirector
- Offering amount
- $83.5M
- Amount sold
- $83.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$49MraisedNov 2022 · 45 investors · BiotechnologyRule 506(b)
▶$49MraisedNov 2022 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zach ScheinerDirector
- Evert SchimmelpenninkExecutive Officer, Director
- James McCollumDirector
- Clare OzawaDirector
- Fred GuerardDirector
- Offering amount
- $49M
- Amount sold
- $49M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedSep 2020 · 25 investors · PharmaceuticalsRule 506(b)
▶$250KraisedSep 2020 · 25 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark LesterExecutive Officer, Director
- James W. McCollumExecutive Officer, Director
- Gerald HornExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Aug 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedJun 2016 · 45 investors · PharmaceuticalsRule 506(b)
▶$3.4MraisedJun 2016 · 45 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- MARK LESTERExecutive Officer
- JAMES McCOLLUMExecutive Officer
- GERALD HORNExecutive Officer
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- Minimum investment
- $2.4K
- First sale
- Jun 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Presbyopia Therapies?
- Presbyopia Therapies was founded by GERALD HORN in 2013.
- Who are Presbyopia Therapies's investors?
- Presbyopia Therapies's investors include Versant Ventures.
- How much funding has Presbyopia Therapies raised?
- Presbyopia Therapies has disclosed $136.2M raised across 4 rounds.
- Where is Presbyopia Therapies headquartered?
- Presbyopia Therapies is headquartered in Coronado, US.